newsfilter
← Latest News
GlobeNewswire·

Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference

Video webcast now available here CAMBRIDGE, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (NASDAQ:ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and